Out Of The Black Hole

MAP Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual … – CNNMoney.com (press release)

 
MAP Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual
CNNMoney.com (press release)
The company is developing LEVADEX(TM) orally inhaled therapy for the potential treatment of migraine and has reported positive results from the efficacy

and more »

Continue reading …

Other articles you might like;

Share and Enjoy:
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks
  • Blogplay
  • Twitter

Related posts:

  1. MAP Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual … – CNNMoney.com (press release)
  2. MAP Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual … – CNNMoney.com (press release)
  3. MAP Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual … – CNNMoney.com (press release)
© 2009. All Rights Reserved